First Time Loading...

Anebulo Pharmaceuticals Inc
NASDAQ:ANEB

Watchlist Manager
Anebulo Pharmaceuticals Inc Logo
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Watchlist
Price: 2.17 USD 0.23% Market Closed
Updated: Jun 8, 2024

Anebulo Pharmaceuticals Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Anebulo Pharmaceuticals Inc
Accrued Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Accrued Liabilities
$530k
CAGR 3-Years
198%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Accrued Liabilities
$28.7B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
8%
Bristol-Myers Squibb Co
NYSE:BMY
Accrued Liabilities
$9.9B
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
13%
Pfizer Inc
NYSE:PFE
Accrued Liabilities
$2.2B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Accrued Liabilities
$13.1B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Accrued Liabilities
$10.3B
CAGR 3-Years
17%
CAGR 5-Years
16%
CAGR 10-Years
16%

See Also

What is Anebulo Pharmaceuticals Inc's Accrued Liabilities?
Accrued Liabilities
530k USD

Based on the financial report for Jun 30, 2023, Anebulo Pharmaceuticals Inc's Accrued Liabilities amounts to 530k USD.

What is Anebulo Pharmaceuticals Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
198%

Over the last year, the Accrued Liabilities growth was 308%. The average annual Accrued Liabilities growth rates for Anebulo Pharmaceuticals Inc have been 198% over the past three years .